Amgen Australia Pty Ltd
Regulatory activities for this sponsor.
Results for "[search-keyword]"
- Australian Public Assessment Report (AusPAR)AusPAR for Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy for advanced disease.
- ARTGAustralian Register of Therapeutic Goods (ARTG) information for Amgen Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.